<h3 id="tldr">TLDR</h3>
<ul>
 <li>Stock futures advanced Tuesday following the Nasdaq Composite’s 23rd record close of 2026</li>
 <li>Nvidia (NVDA) shares climbed 0.9% to $241.05 after Monday’s all-time closing record of $298.90</li>
 <li>Lucid Group (LCID) added 0.2% following third-quarter data showing deliveries exceeded production</li>
 <li>Nike (NKE) fell 1.3%, adding to a 47% year-to-date decline following disappointing guidance</li>
 <li>Option Care Health (OPCH) skyrocketed 22% amid reports of a potential $5 billion buyout</li>
</ul>
U.S. stock futures pushed higher in early Tuesday trading, building on momentum from a banner session that saw the Nasdaq Composite reach another milestone.
The tech-heavy benchmark notched its 23rd record close of the year during Monday’s session, propelled by strength in technology shares.
Shares of Nvidia advanced 0.9% to $241.05 in premarket activity. The semiconductor giant had already achieved an all-time closing record of $298.90 during the previous session.
<a href="https://knockoutstocks.com/stock/NVDA" rel="noopener noreferrer nofollow"> <img src="https://knockoutstocks.com/api/stocks/NVDA/embed" alt="NVDA Stock Card"> NVIDIA Corporation, NVDA </a>
<h3 id="ai-supply-chain-strength-lifts-chip-stocks">AI Supply Chain Strength Lifts Chip Stocks</h3>
The chipmaker’s premarket advance followed robust quarterly results from Foxconn, a key partner in AI server manufacturing. Although Foxconn’s stock declined 2.64%, the positive earnings reinforced investor optimism about AI infrastructure demand.
Semiconductor stocks have been primary contributors to 2026’s equity market rally, with Nvidia positioned as a central beneficiary of the AI investment wave.
Lucid Group shares inched 0.2% higher Tuesday morning. The EV manufacturer reported third-quarter deliveries surpassed production volumes for the second consecutive quarter.
The delivery-to-production ratio reflects Lucid’s operational restructuring efforts, which aim to generate $1.4 billion in cash flow improvements.
Drawing down existing inventory represents a critical component of the company’s turnaround strategy. Tuesday’s delivery figures indicate tangible headway toward that objective.
Nike shares slid 1.3% in premarket trading, extending a painful year for the athletic apparel giant.
The stock has plummeted 47% through Monday’s session. Management’s cautious forward guidance issued last week did little to restore confidence among shareholders.
The company has yet to provide specific timing for when performance metrics might stabilize. Market participants continue monitoring for concrete evidence of operational improvement.
Multiple corporations are scheduled to release quarterly results this week. Lamb Weston and RPM International were slated to report before Tuesday’s market open.
Constellation Brands, Neogen, Penguin Solutions, and Worthington Steel have earnings calls scheduled after the closing bell. Penguin Solutions declined 1.06% during early trading activity.
<h3 id="notable-stock-movements-tuesday">Notable Stock Movements Tuesday</h3>
Option Care Health shares rocketed 22% higher following media reports that McKesson and private equity firm Clayton, Dubilier &amp; Rice are in advanced discussions to purchase the specialty infusion services provider.
According to sources familiar with the matter, the transaction could assign Option Care Health an enterprise value exceeding $5 billion. The parties have not finalized definitive terms.
Constellation Energy shares climbed 3% on reports that Alphabet, Google’s parent company, is approaching a long-term agreement to purchase $1 billion or more in nuclear power from the energy provider.
An announcement could come within days, though specific details regarding capacity volumes and geographic locations remain undisclosed.
Freshworks shares appreciated 4% after S&amp;P Dow Jones Indices announced the software company will join the S&amp;P SmallCap 600 index, replacing BioLife Solutions. The index rebalancing becomes effective prior to Thursday, October 8 market opening.
Vaxcyte shares retreated 4% following the biotech company’s announcement of dual public offerings: $500 million in common stock and pre-funded warrants, alongside $500 million in convertible senior notes maturing in 2032.
Spyre Therapeutics declined 3.5% after pricing an equity offering of 4.12 million shares at $85.00 each, anticipating approximately $350 million in gross proceeds.
United Microelectronics dropped 2.2% despite reporting September revenue of NT$25.35 billion, representing 27.22% year-over-year growth. The semiconductor manufacturer also disclosed plans to issue $1.8 billion in unsecured overseas convertible bonds.
The post <a href="https://blockonomi.com/option-care-health-soars-22-on-5-billion-acquisition-reports/" rel="noopener noreferrer nofollow">Option Care Health Soars 22% on $5 Billion Acquisition Reports</a> appeared first on <a href="https://blockonomi.com" rel="noopener noreferrer nofollow">Blockonomi</a>.

Option Care Health Soars 22% on $5 Billion Acquisition Reports

Table of Contents

Blockonomi

Other articles published on Oct 6, 2026

Join our free newsletter for daily crypto updates!